Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00280163 · ClinicalTrials.gov registry record
Genomics and Postoperative Atrial Fibrillation
A clinical trial of Postoperative Atrial Fibrillation, Genomics, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 336
- Enrollment target
- 1
- Study location
NCT00280163: Completed study of Postoperative Atrial Fibrillation, Genomics, sponsored by University of Pittsburgh.
NCT00280163 is a study of Postoperative Atrial Fibrillation, Genomics that has completed, run by University of Pittsburgh. The registered enrollment target is 336 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00280163, a study of Postoperative Atrial Fibrillation, Genomics, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 336 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aware, the DNA (Deoxyribonucleic acid) is a chemical in our body that carries the genetic information. There are common but very small variations (polymorphisms) that occur in DNA. We would like to find out if these common variations put a person at increased risk for developing complications- especially rapid irregular heart beat after the CABG operation.
Conditions Studied
Study Locations (1)
Pennsylvania
- UPMC PUH - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 336 participants |
| Start Date | 2005-11 |
| Est. Completion | 2011-02 |
What the finished NCT00280163 record still lists
NCT00280163 is an observational study that tracks outcomes without assigning an intervention. The registered 336 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Postoperative Atrial Fibrillation, Genomics appearing as the primary indexed condition, and to 0 interventions.
NCT00280163 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00280163 about?
NCT00280163 is a clinical study titled "Genomics and Postoperative Atrial Fibrillation". This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aware, the DNA (Deoxyribonucleic acid) is a chemical in our body that carries the genetic information. There are c...
What is the current status of trial NCT00280163?
This trial is currently completed. The enrollment target is 336 participants. The study started on 2005-11. Estimated completion is 2011-02.
What conditions does trial NCT00280163 study?
This clinical trial studies the following conditions: Postoperative Atrial Fibrillation, Genomics.
Who is sponsoring clinical trial NCT00280163?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00280163 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- NCT03977207 · 336 participants · NA
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
- NCT04665206 · 336 participants · Phase 1
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- NCT05124457 · 336 participants · Phase 2
DETERMINE: Detemir vs NPH
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia